Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-β 1 in patients with chronic kidney disease

Nephron - Clinical Practice

Volumn 119, Issue 2, 2011, Pages

  Lepenies, Julia ^a,b   Eardley, Kevin S ^b   Kienitz, Tina ^c   Hewison, Martin ^d   Ihl, Thomas ^c   Stewart, Paul M ^e   Cockwell, Paul ^b   Quinkler, Marcus ^c  

^a KfH Dialysis Center   (Germany)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Chronic kidney disease; Interleukin 6; Macrophage chemoattractant protein 1; Proteinuria; Toll like receptor 4; Transforming growth factor 1

Indexed keywords

INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEINURIA; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHEMOKINE CCL2; CHRONIC DISEASE; CREATININE; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; INTERLEUKIN-1; ISCHEMIA; KIDNEY; MACROPHAGES; MALE; MIDDLE AGED; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; YOUNG ADULT;

EID: 79958767773     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000324765     Document Type: Article

References (39)

1. Akira S, Takeda K, Kaisho T: Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680. (Pubitemid 32747155)
2. Saemann MD, Weichhart T, Zeyda M, et al: Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 2005; 115: 468-475. (Pubitemid 40385489)
3. Tesar BM, Goldstein DR: Toll-like receptors and their role in transplantation. Front Biosci 2007; 12: 4221-4238.
4. Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A: Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 2005; 204: 27-42. (Pubitemid 40460491)
5. Ishii KJ, Coban C, Akira S: Manifold mechanisms of Toll-like receptor-ligand recognition. J Clin Immunol 2005; 25: 511-521. (Pubitemid 43011743)
6. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, Rysz J: The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 2010; 6: 224-235.
7. Arbour NC, Lorenz E, Schutte BC, et al: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-191. (Pubitemid 30394990)
8. Feterowski C, Emmanuilidis K, Miethke T, et al: Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 2003; 109: 426-431. (Pubitemid 36783269)
9. El-Achkar TM, Huang X, Plotkin Z, Sandoval RM, Rhodes GJ, Dagher PC: Sepsis induces changes in the expression and distribution of Toll-like receptor-4 in the rat kidney. Am J Physiol Renal Physiol 2006; 290:F1034-F1043. (Pubitemid 43724902)
10. Zager RA, Johnson AC, Lund S, Randolph-Habecker J: Toll-like receptor (TLR4) shedding and depletion: Acute proximal tubular cell responses to hypoxic and toxic injury. Am J Physiol Renal Physiol 2007; 292:F304-F312. (Pubitemid 46105270)
11. Tsuboi N, Yoshikai Y, Matsuo S, et al: Roles of Toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 2002; 169: 2026-2033. (Pubitemid 34857667)
12. Patole PS, Pawar RD, Lech, M et al: Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant 2006; 21: 3062-3073. (Pubitemid 44567076)
13. Samuelsson P, Hang L, Wullt B, Irjala H, Svanborg C: Toll-like receptor-4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun 2004; 72: 3179-3186. (Pubitemid 38697738)
14. Wolfs TG, Buurman WA, van Schadewijk A, et al: In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-α and TNF-α mediated up-regulation during inflammation. J Immunol 2002; 168: 1286-1293. (Pubitemid 34094497)
15. El-Achkar TM, Wu XR, Rauchman M, Mc-Cracken R, Kiefer S, Dagher PC: Tamm-Horsfall protein protects the kidney from ischemic injury by decreasing inflammation and altering TLR4 expression. Am J Physiol Renal Physiol 2008; 295:F534-F544.
16. Wu H, Chen G, Wyburn KR, et al: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859. (Pubitemid 47529615)
17. Pulskens WP, Teske GJ, Butter LM, et al: Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/ reperfusion injury. PLoS One 2008; 3:e3596.
18. Shirali AC, Goldstein DR: Tracking the toll of kidney disease. J Am Soc Nephrol 2008; 19: 1444-1450.
19. Palmer SM, Burch LH, Mir S, et al: Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 2006; 20: 30-36. (Pubitemid 43349021)
20. Ducloux D, Deschamps M, Yannaraki M, et al: Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005; 67: 2454-2461. (Pubitemid 41623410)
21. Kwon J, Park J, Lee D, Kim YS, Jeong HJ: Tolllike receptor expression in patients with renal allograft dysfunction. Transplant Proc 2008; 40: 3479-3480.
22. Kruger B, Krick S, Dhillon N, et al: Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395.
23. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
25. Bujalska IJ, Walker EA, Tomlinson JW, Hewison M, Stewart PM: 11 β-Hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: From deactivation to generation of cortisol. Endocr Res 2002; 28: 449-461. (Pubitemid 36042500)
26. Quinkler M, Zehnder D, Eardley KS, et al: Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation 2005; 112: 1435-1443. (Pubitemid 41291769)
27. Thomas ME, Harris KP, Walls J, Furness PN, Brunskill NJ: Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria. Am J Physiol Renal Physiol 2002; 283:F640-F647. (Pubitemid 35033950)
28. Peterson JC, Adler S, Burkart JM, et al: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-762.
29. Remuzzi G, Tognoni G: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, nondiabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997; 349: 1857-1863. (Pubitemid 27270118)
30. Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB: TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 2008; 19: 923-932.
31. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ: Role of Toll-like receptor-4 in endotoxin-induced acute renal failure. J Immunol 2004; 172: 2629-2635. (Pubitemid 38182415)
32. Deng JF, Geng L, Qian YG, et al: The role of Toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation. Transplant Proc 2007; 39: 3222-3224. (Pubitemid 350251413)
33. Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG: Toll-like receptor-4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol 2007; 18: 1732-1739. (Pubitemid 46870310)
34. Lim BJ, Hong SW, Jeong HJ: Renal tubular expression of Toll-like receptor-4 in cyclosporine nephrotoxicity. APMIS 2009; 117: 583-591.
35. Campbell MT, Hile KL, Zhang H, et al: Toll-like receptor-4: A novel signaling pathway during renal fibrogenesis. J Surg Res 2009, Oct 23 [Epub ahead of print].
36. Wang WM, Zhang HD, Jin YM, Zhu BB, Chen N: PPAR-γ agonists inhibit TGF-β1 -induced chemokine expression in human tubular epithelial cells. Acta Pharmacol Sin 2009; 30: 107-112.
37. Li H, Ruan XZ, Powis SH, et al: EPA and DHA reduce lipopolysaccharide- induced inflammation responses in HK-2 cells: Evidence for a PPAR-γ -dependent mechanism. Kidney Int 2005; 67: 867-874. (Pubitemid 41623311)
38. Schauber J, Dorschner RA, Coda AB, et al: Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007; 117: 803-811. (Pubitemid 46348539)
39. Gollapudi P, Yoon JW, Gollapudi S, Pahl MV, Vaziri ND: Leukocyte Toll-like receptor expression in end-stage kidney disease. Am J Nephrol 2010; 31: 247-254.